On July 9, 2026, a groundbreaking study revealed a new neutron method that uncovers the inner architecture of drug delivery nanoparticles. This research, conducted by an international team including scientists from the Leibniz Institute for Polymer Research and the Institut Laue-Langevin, demonstrates how advanced techniques can enhance the understanding of nanoparticles crucial for safe and effective medical treatments.
Understanding Drug Delivery Nanoparticles
Modern medicine increasingly relies on targeted drug delivery, where therapeutic molecules are transported directly to specific organs or cell types. These treatments utilize biocompatible nanoparticles, often made from various fat molecules, to package drugs effectively. The efficiency of this delivery process is influenced by the particles' size, shape, and internal structure.
Manufacturers typically monitor nanoparticle size distribution, as international quality standards dictate that sizes must not vary by more than 30% to ensure safety. A technique known as asymmetric-flow field-flow fractionation (AF4) is commonly employed. This method separates particles in solution, allowing smaller particles to move faster than larger ones, thereby ensuring accurate size measurement.
Innovative Analytical Techniques
The study highlights a novel combination of AF4 with small-angle neutron scattering (SANS), a method previously unutilized for this purpose. By coupling these techniques, researchers can analyze nanoparticles with unprecedented detail. The innovative experimental setup, performed on the ILL's D11 instrument, allowed for simultaneous measurement of particle size and internal organization.
